B. Wittmann

发表

Bladder Cancer Biomarker Discovery Using Global Metabolomic Profiling of Urine

Y. Lotan, B. Wittmann, S. Stirdivant, 2014, PloS one.

[Frontiers in Bioscience 10, 1440-1461 May 1, 2005] 1440 ESTROGEN RECEPTOR REGULATION OF QUINONE REDUCTASE IN BREAST CANCER: IMPLICATIONS FOR ESTROGEN-INDUCED BREAST TUMOR GROWTH AND THE THERAPEUTIC USES OF TAMOXIFEN

B. Wittmann, M. Montano, Huayun Deng, 2005 .

Estrogen receptor regulation of quinone reductase in breast cancer: implications for estrogen-induced breast tumor growth and therapeutic uses of tamoxifen.

B. Katzenellenbogen, B. Wittmann, M. Montano, 2005, Frontiers in bioscience : a journal and virtual library.

Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators.

B. Wittmann, D. McDonnell, Bryan M. Wittmann, 2007, Cancer research.

Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer.

D. Edwards, B. Wittmann, D. Kazmin, 2010, Molecular endocrinology.

Identification and Characterization of a Novel Factor That Regulates Quinone Reductase Gene Transcriptional Activity*

B. Wittmann, M. Montano, Bryan M. Wittmann, 2000, The Journal of Biological Chemistry.

Altered Plasma Mitochondrial Metabolites in Persistently Symptomatic Individuals after a GBCA-Assisted MRI

L. Koran, B. Wittmann, Bryan M. Wittmann, 2022, Toxics.

Identification of a novel inhibitor of breast cell growth that is down-regulated by estrogens and decreased in breast tumors.

B. Wittmann, M. Montano, Bryan M. Wittmann, 2003, Cancer research.

HEXIM1 plays a critical role in the inhibition of the androgen receptor by anti-androgens.

B. Wittmann, M. Montano, D. Danielpour, 2014, The Biochemical journal.

Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer.

D. Edwards, B. Wittmann, D. Kazmin, 2010, Molecular endocrinology.